V. Quevedo Vila

Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry)

A. Fernández-Nebro, M. Rodríguez-Gómez, C. Marras, 2019, Lupus.

Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality

A. Fernández-Nebro, J. Ovalles, I. Castellví, 2020, Lupus.

Prevalence of symptomatic axial osteoarthritis phenotypes in Spain and associated socio-demographic, anthropometric, and lifestyle variables

F. Perez-Ruiz, J. Pego-Reigosa, C. Sánchez-Piedra, 2021, Rheumatology International.

Prevalence of rheumatic diseases in adult population in Spain (EPISER 2016 study): Aims and methodology.

F. Blanco, A. Olivé, J. Pego-Reigosa, 2019, Reumatologia clinica.

Prevalence of symptomatic osteoarthritis in Spain: EPISER2016 study.

F. Blanco, J. Pego-Reigosa, C. Sánchez-Piedra, 2020, Reumatologia clinica.

Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients?

J. Ovalles, I. Castellví, J. Calvo-Alén, 2020, Clinical and Experimental Rheumatology.

Prevalence of symptomatic osteoarthritis in Spain: EPISER2016 study.

F. Blanco, J. Pego-Reigosa, C. Sánchez-Piedra, 2020, Reumatología Clínica.

Prevalence of rheumatic diseases in adult population in Spain (EPISER 2016 study): Aims and methodology.

Sagrario Bustabad, J. Pego-Reigosa, C. Sánchez-Piedra, 2017, Reumatologia clinica.